NMT2 Antibody (OTI1G3)

N-myristoyltransferase (NMT) catalyzes the reaction of N-terminal myristoylation of many signaling proteins. It transfers myristic acid from myristoyl coenzyme A to the amino group of a protein's N-terminal glycine residue. Biochemical evidence indicates the presence of several distinct NMTs, varying in apparent molecular weight and /or subcellular distribution. The predicted 498-amino acid of human NMT2 protein shares 77% and 96% sequence identity with human NMT1 and mouse Nmt2 comprise two distinct families of N-myristoyltransferases. [provided by RefSeq].

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 1 application: FLOW.

Showing Publication 1 - 1 of 1.

Publication using NBP2-01676	Applications	Species
Wen Z, Jin K, Shen Y et al. N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation Nat. Immunol. 2019-03-01 [PMID: 30718913] (FLOW, Human)	FLOW	Human

Array NBP2-01676

• NMT2 Antibodies
• NMT2 Lysate
• NMT2 Proteins